Landscape Capital Management, L.L.C. Galapagos Nv Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $427,546 - $538,754	-4,869 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$90.63 - $120.22 $192,860 - $255,828	-2,128 Reduced 30.41%	4,869 $547,000
Q2 2018 Aug 14, 2018	SELL	$88.4 - $105.34 $609,783 - $726,635	-6,898 Reduced 49.64%	6,997 $645,000
Q1 2018 May 11, 2018	BUY	$94.51 - $120.23 $921,850 - $1.17 Million	9,754 Added 235.55%	13,895 $1.39 Million
Q4 2017 Feb 13, 2018	BUY	$84.48 - $104.02 $75,525 - $92,993	894 Added 27.53%	4,141 $388,000
Q3 2017 Nov 14, 2017	SELL	$73.17 - $103.47 $244,534 - $345,796	-3,342 Reduced 50.72%	3,247 $330,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,589	6,589 $504,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.